These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9528894)

  • 1. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD).
    Giacomelli R; Passacantando A; Parzanese I; Vernia P; Klidara N; Cucinelli F; Lattanzio R; Santori E; Cipriani P; Caprilli R; Tonietti G
    Clin Exp Immunol; 1998 Mar; 111(3):532-5. PubMed ID: 9528894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring?
    Fabian O; Klocperk A; Lerchova T; Jencova P; Stolova L; Belhajova M; Voriskova D; Kazeka D; Vicha A; Hradsky O; Bronsky J
    Dig Dis Sci; 2023 Feb; 68(2):460-470. PubMed ID: 36056999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
    Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
    World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for T lymphocyte reactivity to the 65 kilodalton heat shock protein of mycobacterium in active Crohn's disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Dec; 15(6):494-505. PubMed ID: 1286531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
    Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
    Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune system alterations in patients with inflammatory bowel disease during remission.
    Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
    Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool?
    Rizzo R; Melchiorri L; Simone L; Stignani M; Marzola A; Gullini S; Baricordi OR
    Inflamm Bowel Dis; 2008 Jan; 14(1):100-5. PubMed ID: 17886287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Fabian O; Hradsky O; Drskova T; Mikus F; Zamecnik J; Bronsky J
    Dig Dis Sci; 2018 Jul; 63(7):1811-1818. PubMed ID: 29541900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls.
    Bouma G; Oudkerk Pool M; Scharenberg JG; Kolkman JJ; von Blomberg BM; Scheper RJ; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Nov; 30(11):1095-100. PubMed ID: 8578170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30-mediated signaling promotes the development of human T helper type 2-like T cells.
    Del Prete G; De Carli M; D'Elios MM; Daniel KC; Almerigogna F; Alderson M; Smith CA; Thomas E; Romagnani S
    J Exp Med; 1995 Dec; 182(6):1655-61. PubMed ID: 7500010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease.
    Giacomelli R; Cipriani P; Lattanzio R; Di Franco M; Locanto M; Parzanese I; Passacantando A; Ciocci A; Tonietti G
    Clin Exp Immunol; 1997 Apr; 108(1):42-6. PubMed ID: 9097909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
    Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
    Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
    Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
    Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
    Kucharzik T; Stoll R; Lügering N; Domschke W
    Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.
    D'Elios MM; Romagnani P; Scaletti C; Annunziato F; Manghetti M; Mavilia C; Parronchi P; Pupilli C; Pizzolo G; Maggi E; Del Prete GF; Romagnani S
    J Leukoc Biol; 1997 May; 61(5):539-44. PubMed ID: 9129201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.